Skip to main content

Advertisement

ADVERTISEMENT

News

Heart Failure
08/20/2024
V-Wave’s Ventura® Interatrial Shunt (IAS) is a novel implantable device designed to decrease elevated left atrial pressure seen in congestive heart failure by creating a shunt between the left and right atrium, thereby reducing cardiovascular...
V-Wave’s Ventura® Interatrial Shunt (IAS) is a novel implantable device designed to decrease elevated left atrial pressure seen in congestive heart failure by creating a shunt between the left and right atrium, thereby reducing cardiovascular...
V-Wave’s Ventura® Interatrial...
08/20/2024
Cath Lab Digest
Direct Oral Anticoagulants (DOACs)
08/20/2024
“Direct oral anticoagulants may be viewed as simpler to manage than traditional blood thinners, like warfarin, but our results highlight why providers need to be consistently monitoring anticoagulant medications before a patient experiences...
“Direct oral anticoagulants may be viewed as simpler to manage than traditional blood thinners, like warfarin, but our results highlight why providers need to be consistently monitoring anticoagulant medications before a patient experiences...
“Direct oral anticoagulants may...
08/20/2024
Cath Lab Digest
Aneurysms
08/20/2024
In order to find out what distinguishes the repeatedly affected vascular regions from others, Daniela Wenzel and her team developed a method to specifically examine the endothelium of the aorta. “We know from other vascular diseases such as...
In order to find out what distinguishes the repeatedly affected vascular regions from others, Daniela Wenzel and her team developed a method to specifically examine the endothelium of the aorta. “We know from other vascular diseases such as...
In order to find out what...
08/20/2024
Cath Lab Digest

Advertisement

Cardiac Arrest
08/20/2024
A recent study by UC Davis Health researchers set out to assess the effects of giving naloxone administration by paramedics to patients with OHCA. The study concluded there was an association between naloxone administration, and both return...
A recent study by UC Davis Health researchers set out to assess the effects of giving naloxone administration by paramedics to patients with OHCA. The study concluded there was an association between naloxone administration, and both return...
A recent study by UC Davis...
08/20/2024
Cath Lab Digest
Treatment Pathways
08/20/2024
Cleveland Clinic News Cleveland Clinic researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease. The Nature Communications study found...
Cleveland Clinic News Cleveland Clinic researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease. The Nature Communications study found...
Cleveland Clinic...
08/20/2024
Cath Lab Digest
Genetics
08/19/2024
Researchers at Edith Cowan University's (ECU's) Centre for Precision Health have uncovered a significant genetic connection between Alzheimer's disease (AD) and several coronary artery disease (CAD) related disorders and lipid classes,...
Researchers at Edith Cowan University's (ECU's) Centre for Precision Health have uncovered a significant genetic connection between Alzheimer's disease (AD) and several coronary artery disease (CAD) related disorders and lipid classes,...
Researchers at Edith Cowan...
08/19/2024
Cath Lab Digest

Advertisement

Structural Heart Business
08/19/2024
Genesis MedTech has sold JC Medical, Inc. to Edwards Lifesciences, including the intellectual property and commercial rights of its J-Valve® System, a transcatheter aortic valve replacement for the treatment of severe aortic regurgitation.
Genesis MedTech has sold JC Medical, Inc. to Edwards Lifesciences, including the intellectual property and commercial rights of its J-Valve® System, a transcatheter aortic valve replacement for the treatment of severe aortic regurgitation.
Genesis MedTech has sold JC...
08/19/2024
Cath Lab Digest
Vascular Closure
08/15/2024
The VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch...
The VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch...
The VASCADE MVP XL system is now...
08/15/2024
EP Lab Digest
Pulmonary Embolism
08/15/2024
Jupiter Endovascular is developing the endoportal procedure, using Endoportal Control™ to bring the precision and control of direct surgical access to catheter-based interventions. The procedure uses an endoportal device that navigates...
Jupiter Endovascular is developing the endoportal procedure, using Endoportal Control™ to bring the precision and control of direct surgical access to catheter-based interventions. The procedure uses an endoportal device that navigates...
Jupiter Endovascular is...
08/15/2024
Cath Lab Digest

Advertisement

ACC ASIA 2024
08/15/2024
According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of caffeine per day on most days of the week could increase the susceptibility of otherwise healthy individuals to cardiovascular disease.
According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of caffeine per day on most days of the week could increase the susceptibility of otherwise healthy individuals to cardiovascular disease.
According to a new study being...
08/15/2024
Cath Lab Digest

Advertisement